Letall 2.5 mg Tablet
  1. Home
  2. Pharma Products
  3. Intas Pharmaceuticals Ltd
  4. Letall 2.5 mg Tablet

Letall 2.5 mg Tablet

Letall 2.5 mg Tablet contains letrozole 2.5 mg, an oral aromatase inhibitor used in hormone-sensitive breast cancer treatment. It is mainly prescribed for hormone-receptor-positive breast cancer in postmenopausal women. The tablet is a prescription medicine and should be taken under specialist medical supervision.

BUY NOW

Category

Letrozole lowers estrogen production by inhibiting the aromatase enzyme, reducing hormonal stimulation of breast cancer cells. It may be used for early, advanced, or recurrent hormone-sensitive breast cancer according to the prescribed treatment plan. Long-term treatment may require monitoring of bone health and cholesterol because reduced estrogen can affect bone mineral density and lipid levels. The dose and duration are determined by the treating specialist according to the patient’s condition and treatment response.

Technical Specification

Specification Details
Active Ingredient Letrozole
Strength 2.5 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 10 tablets
Manufacturer / Marketer Intas Pharmaceuticals Ltd

Product Also Known As

Letall 2.5mg Tablet, Letall 2.5 mg Tablet, Letall 2.5 Tablet, Letrozole 2.5mg Tablet, Letrozole 2.5 mg Tablet, Letrozole Oral Tablet, Letrozole Breast Cancer Tablet